Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY – Get Free Report)’s stock price was up 1.9% during trading on Thursday . The stock traded as high as $57.57 and last traded at $57.57. Approximately 628 shares changed hands during mid-day trading, a decline of 38% from the average daily volume of 1,018 shares. The stock had previously closed at $56.51.
Hikma Pharmaceuticals Price Performance
The business’s 50 day moving average is $50.38 and its 200 day moving average is $50.28.
About Hikma Pharmaceuticals
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.
See Also
- Five stocks we like better than Hikma Pharmaceuticals
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- How to buy stock: A step-by-step guide for beginners
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- What is the NASDAQ Stock Exchange?
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
